Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic Review

PLoS Neglected Tropical Diseases

Volumn 10, Issue 2, 2016, Pages

  Brainard, Julii ^a   Pond, Katherine ^b   Hooper, Lee ^a   Edmunds, Kelly ^a   Hunter, Paul ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BODY FLUID; DISEASE TRANSMISSION; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; FILOVIRUS INFECTION; HUMAN; INFECTION RISK; LIMIT OF DETECTION; MARBURG HEMORRHAGIC FEVER; MARBURGVIRUS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SEMEN ANALYSIS; SEMINAL PLASMA; SPUTUM ANALYSIS; SURVIVOR; SYSTEMATIC REVIEW; TISSUE CULTURE; URINALYSIS; VIREMIA; VIRUS LOAD; ANIMAL; GENETICS; ISOLATION AND PURIFICATION; MORTALITY; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ANIMALS; BODY FLUIDS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MARBURG VIRUS DISEASE; MARBURGVIRUS; SURVIVORS;

EID: 84959257913     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004475     Document Type: Article

References (67)

1. Leroy EM, Epelboin A, Mondonge V, Pourrut X, Gonzalez J-P, et al. (2009) Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne and Zoonotic Diseases9: 723–728. doi: 10.1089/vbz.2008.016719323614
2. Milleliri J, Tevi-Benissan C, Baize S, Leroy E, Georges-Courbot M, (2004) [Epidemics of Ebola haemorrhagic fever in Gabon (1994–2002). Epidemiologic aspects and considerations on control measures]. Bulletin de la Societe de pathologie exotique (1990)97: 199–205.
3. Kawaoka Y, (2005) How Ebola virus infects cells. New England Journal of Medicine352: 2645–2646. 15972874
4. Feldmann H, Geisbert TW, (2011) Ebola haemorrhagic fever. Lancet377: 849–862. doi: 10.1016/S0140-6736(10)60667-821084112
5. Bibby K, Casson LW, Stachler E, Haas CN, (2014) Ebola virus persistence in the environment: State of the knowledge and research needs. Environmental Science & Technology Letters.
6. WHO (2014) Ebola Virus Disease (EVD): Key questions and answers concerning water, sanitation and hygiene. In: Organisation WH, editor. WHO/EVD/WSH/14.
7. Burke J, Declerq R, Ghysebrechts G, Pattyn S, Piot P, et al. (1978) Ebola hemorragic-fever in Zaire, 1976—Report of an International Commission. Bulletin of the World Health Organization56: 271–293. 307456
8. Jezek Z, Szczeniowski M, Muyembe-Tamfum J, McCormick J, Heymann D, (1999) Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 1981–1985. Journal of Infectious Diseases179: S60–S64. 9988166
9. Leroy E, Baize S, Volchkov V, Fisher-Hoch S, Georges-Courbot M, et al. (2000) Human asymptomatic Ebola infection and strong inflammatory response. Lancet355: 2210–2215. 10881895
10. Nkoghe D, Padilla C, Becquart P, Wauquier N, Moussavou G, et al. (2011) Risk factors for Zaire ebolavirus–specific IgG in rural Gabonese populations. Journal of Infectious Diseases204: S768–S775. doi: 10.1093/infdis/jir34421987749
11. Kuhn J, Calisher CH, (2008) Filoviruses: a compendium of 40 years of epidemiological, clinical, and laboratory studies: Springer Science & Business Media.
12. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of internal medicine151: W-65–W-94.
13. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, et al. (2007) Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. Journal of Infectious Diseases196: S142–S147. 17940942
14. Ksiazek T, Rollin P, Williams A, Bressler D, Martin M, et al. (1999) Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases179: S177–S187. 9988182
15. Liu L, Sun Y, Kargbo B, Zhang C, Feng H, et al. (2015) Detection of Zaire Ebolavirus by Real-Time Reverse Transcription-Polymerase Chain Reaction, Sierra Leone, 2014. Journal of Virological Methods222: 62–65. doi: 10.1016/j.jviromet.2015.05.00526025458
16. Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum J, et al. (1999) Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Journal of Infectious Diseases179: S28–S35. 9988162
17. Rodriguez L, De Roo A, Guimard Y, Trappier S, Sanchez A, et al. (1999) Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases179: S170–S176. 9988181
18. McElroy AK, Akondy RS, Davis CW, Ellebedy AH, Mehta AK, et al. (2015) Human Ebola virus infection results in substantial immune activation. Proceedings of the National Academy of Sciences of the United States of America112: 4719–4724. doi: 10.1073/pnas.150261911225775592
19. Spengler JR, McElroy AK, Harmon JR, Ströher U, Nichol ST, et al. (2015) Relationship Between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction–Based Threshold Cycle Value and Virus Isolation From Human Plasma. Journal of Infectious Diseases: jiv187.
20. Emond R, Evans B, Bowen E, Lloyd G, (1977) A case of Ebola virus infection. British Medical Journal2: 541–544. 890413
21. Baron RC, McCormick JB, Zubeir OA, (1983) Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bulletin of the World Health Organization61: 997. 6370486
22. Richards GA, Murphy S, Jobson R, Mer M, Zinman C, et al. (2000) Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Critical care medicine28: 240–244. 10667531
23. Formenty P, Leroy EM, Epelboin A, Libama F, Lenzi M, et al. (2006) Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clinical Infectious Diseases42: 1521–1526. 16652308
24. Strecker T, Palyi B, Ellerbrok H, Jonckheere S, de Clerck H, et al. (2015) Field evaluation of capillary blood samples as a collection specimen for the rapid diagnosis of Ebola virus infection during an outbreak emergency. Clinical Infectious Diseases: civ397.
25. Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, de Heer G, et al. (2014) A case of severe Ebola virus infection complicated by gram-negative septicemia. New england journal of medicine371: 2394–2401. doi: 10.1056/NEJMoa141167725337633
26. Wolf T, Kann G, Becker S, Stephan C, Brodt H- R, et al. (2015) Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet385: 1428–1435. doi: 10.1016/S0140-6736(14)62384-925534190
27. Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, et al. (2015) The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States. Clinical Infectious Diseases: civ334.
28. Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, et al. (2014) Clinical care of two patients with Ebola virus disease in the United States. New England Journal of Medicine371: 2402–2409. doi: 10.1056/NEJMoa140983825390460
29. Connor MJ, Kraft C, Mehta AK, Varkey JB, Lyon GM, et al. (2014) Successful delivery of RRT in Ebola virus disease. Journal of the American Society of Nephrology: ASN. 2014111057.
30. Mora-Rillo M, Arsuaga M, Ramírez-Olivencia G, de la Calle F, Borobia AM, et al. (2015) Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. Lancet Respiratory Medicine3: 554–562. doi: 10.1016/S2213-2600(15)00180-026041403
31. Liddell AM, Davey RT, JrMehta AK, Varkey JB, Kraft CS, et al. (2015) Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States. Annals of internal medicine Online from 12 May 2015.
32. Florescu DF, Kalil AC, Hewlett AL, Schuh AJ, Stroher U, et al. (2015) Administration of Brincidofovir and Convalescent Plasma in a Patient with Ebola Virus Disease. Clinical Infectious Diseases: civ395.
33. Moreau M, Spencer C, Gozalbes J, Colebunders R, Lefevre A, et al. (2015) Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Euro surveillance20: 3.
34. Akerlund E, Prescott J, Tampellini L, (2015) Shedding of Ebola Virus in an Asymptomatic Pregnant Woman. New England Journal of Medicine372: 2467–2469. doi: 10.1056/NEJMc150327526083224
35. Yacisin K, Balter S, Fine A, Weiss D, Ackelsberg J, et al. (2015) Ebola virus disease in a humanitarian aid worker-new york city, october 2014. MMWR: Morbidity and mortality weekly report64: 321–323. 25837242
36. Express News Service (2014) ‘Cured’ of Ebola disease in Liberia, Indian man isolated in Delhi after a positive test The Indian Express.
37. Wong KK, Perdue CL, Malia J, Kenney JL, Peng S, et al. (2015) Supportive care of the first two Ebola virus disease patients at the Monrovia Medical Unit. Clinical Infectious Diseases: civ420.
38. Schibler M, Vetter P, Cherpillod P, Petty TJ, Cordey S, et al. (2015) Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report. Lancet Infectious Diseases Available online from 19 July 2015.
39. Christie A, Davies-Wayne GJ, Cordier-Lasalle T, Blackley DJ, Laney AS, et al. (2015) Possible sexual transmission of Ebola virus—Liberia, 2015. MMWR: Morbidity and Mortality Weekly Report64: 1–3.
40. Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, et al. (2015) Persistence of Ebola Virus in Ocular Fluid During Convalescence. New England Journal of Medicine372: 2423–2427. doi: 10.1056/NEJMoa150030625950269
41. Martini G, Schmidt H, (1968) Spermatogene Übertragung des "Virus Marburg" (Spermatogenesis Transmission of Marburg Virus). Klinische Wochenschrift46: 398–400. 4971902
42. Martini G, (1973) Marburg virus disease. Postgraduate medical journal49: 542–546. 4207635
43. Gear S, Cassel GA, Gear AJ, Trappler B, Clausen L, et al. (1975) Outbreak of Marburg virus disease in Johannesburg. British Medical Journal4: 489–493. 811315
44. Fujita N, Miller A, Miller G, Gershman K, Gallagher N, et al. (2009) Imported case of Marburg hemorrhagic fever-Colorado, 2008. MMWR: Morbidity and Mortality Weekly Report58: 1377–1381. 20019654
45. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, et al. (2004) Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. Journal of virology78: 4330–4341. 15047846
46. Spinner ML, Di Giovanni GD, (2001) Detection and identification of mammalian reoviruses in surface water by combined cell culture and reverse transcription-PCR. Applied and environmental microbiology67: 3016–3020. 11425715
47. Büttner S, Koch B, Dolnik O, Eickmann M, Freiwald T, et al. (2014) Extracorporeal Virus Elimination for the Treatment of Severe Ebola Virus Disease-First Experience with Lectin Affinity Plasmapheresis. Blood purification38: 286–291. doi: 10.1159/00037522925676045
48. Singh SK, Ruzek D, (2014) Viral hemorrhagic fevers. Boca Raton, LA: CRC Press, Taylor and Francis Group. 444 p.
49. Boldogh I, Albrecht T, Porter DD, Baron S, (1996) Persistent viral infections. In: Medical Microbiology. Galveston TX: University of Texas Medical Branch at Galveston.
50. McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, et al. (2014) Biomarker correlates of survival in pediatric patients with Ebola virus disease. Emerging infectious diseases20: 1683. doi: 10.3201/eid2010.14043025279581
51. Bah EI, Lamah M-C, Fletcher T, Jacob ST, Brett-Major DM, et al. (2015) Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. New England Journal of Medicine372: 40–47. doi: 10.1056/NEJMoa141124925372658
52. Fedson DS, Rordam OM, (2015) Treating Ebola patients: a ‘bottom up’approach using generic statins and angiotensin receptor blockers. International Journal of Infectious Diseases36: 80–84. doi: 10.1016/j.ijid.2015.04.01926143190
53. Fitzpatrick G, Vogt F, Gbabai OBM, Decroo T, Keane M, et al. (2015) The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Médecins Sans Frontières (MSF) Ebola Case Management Centre (CMC), Kailahun, Sierra Leone, June–October, 2014. Journal of Infectious Diseases: jiv304.
54. Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani M, et al. (2003) Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerging infectious diseases9: 1430. 14718087
55. Rodríguez RA, Pepper IL, Gerba CP, (2009) Application of PCR-based methods to assess the infectivity of enteric viruses in environmental samples. Applied and Environmental Microbiology75: 297–307. doi: 10.1128/AEM.01150-0819011062
56. Thormar H, Isaacs C, Brown H, Barshatzky M, Pessolano T, (1987) Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrobial agents and chemotherapy31: 27–31. 3032090
57. Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, et al. (2007) Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet369: 1107–1116. 17398310
58. World Health Organisation (2015) Interim advice on the sexual transmission of the Ebola virus disease. Sexual and reproductive health.
59. IANS (2015) Quarantined Indian discharged after Ebola scare Business Standard. New Delhi.
60. Routh J, (2015) Study of Ebola survivors opens in Liberia. In: Trial to examine long-term health effects of Ebola virus disease: National Institutes of Health.
61. Anonymous (2015) Sierra Leone launches Ebola survivor sex study GBCGhana.
62. MacNeil A, Farnon EC, Morgan OW, Gould P, Boehmer TK, et al. (2011) Filovirus outbreak detection and surveillance: lessons from Bundibugyo. Journal of Infectious Diseases204: S761–S767. doi: 10.1093/infdis/jir29421987748
63. Branswell H, (2014) Infection Secrets of Ebola Explained. Scientific American.
64. Geisbert TW, Jahrling PB, Larsen T, Davis KJ, Hensley L, (2002) Filovirus pathogenesis in nonhuman primates. DTIC Document.
65. Johnson E, Jaax N, White J, Jahrling P, (1995) Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. International journal of experimental pathology76: 227. 7547435
66. Nakayama E, Saijo M, (2013) Animal models for Ebola and Marburg virus infections. Frontiers in microbiology4.
67. World Health Organisation (2015) Ebola virus disease: Fact Sheet No. 103.